SORRISO PHARMACEUTICALS
Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory disease, including Crohn’s disease and ulcerative colitis. The Sorriso platform generates potent antibodies that can be delivered orally and are designed to maintain activity throughout the intestinal system. The company was founded in 2020 and is based in San Diego, California.
SORRISO PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2020-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.sorrisopharma.com
Status:
Active
Email Addresses:
[email protected]
Total Funding:
31 M USD
Similar Organizations
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Current Employees Featured
Founder
Investors List
Arix Bioscience
Arix Bioscience investment in Series A - Sorriso Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Series A - Sorriso Pharmaceuticals
Official Site Inspections
http://www.sorrisopharma.com
- Host name: cloudproxy10026.sucuri.net
- IP address: 192.124.249.26
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Sorriso Pharmaceuticals"
About - Sorriso Pharmaceuticals
Corporate Headquarters 9295 S. 1300 E. #3, Sandy, UT 84094. San Diego, CA. Lab Headquarters Magnify at CNSI, UCLA, Los Angeles, CASee details»
Homepage - Sorriso Pharmaceuticals
Sorriso Pharmaceuticals Presents Positive SOR102 Phase 1b Ulcerative Colitis Data at ECCO ConferenceSee details»
Sorriso Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory …See details»
Sorriso Pharmaceuticals | LinkedIn
Sorriso Pharmaceuticals | 769 followers on LinkedIn. Harnessing the power of oral biologic therapies for patients with chronic illness | Sorriso’s mission is to harness the power of oral ...See details»
Investors - Sorriso Pharmaceuticals
Pappas Capital invests exclusively in the life science sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures – across the United States and Canada.See details»
Sorriso Pharmaceuticals Overview | SignalHire Company Profile
Organization Website. sorrisopharma.com . Phone Number (385) 342-4989. Sorriso Pharmaceuticals industries. Biotech Headquarters Location. San Diego, CA, US. Sorriso …See details»
Sorriso Pharmaceuticals - Products, Competitors, Financials, …
Sorrisopharma.com. Overview & Products; Financials; People; Founded Year 2020. Stage Series A | Alive. Total Raised $31M. Last Raised $31M | 3 yrs ago. Mosaic Score. The Mosaic Score …See details»
Sorriso Pharmaceuticals - PitchBook
Sorriso Pharmaceuticals General Information Description. Developer of disease-modifying antibodies designed for the treatment of inflammatory diseases, including Crohn's disease and ulcerative colitis.See details»
Sorriso Pharmaceuticals - VentureRadar
"Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory disease, including Crohn’s disease and ulcerative …See details»
Sorriso Pharmaceuticals - Employees, Contact info, Overview - Wiza
May 6, 2024 View info about Sorriso Pharmaceuticals (sorrisopharma.com). Sorriso Pharmaceuticals is a company located in san diego, california, united states. Find employees, …See details»
Sorriso Pharmaceuticals - Craft
Sorriso Pharmaceuticals $31 m in total funding,. See insights on Sorriso Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Sorriso Pharmaceuticals - Pappas Capital
Sorriso is a biopharmaceutical company advancing a pipeline of disease-modifying antibodies for the treatment of immune-mediated diseases, including Crohn’s disease and ulcerative colitis.See details»
Sorriso Pharmaceuticals - Arix Bioscience
Dec 22, 2021 www.sorrisopharma.com. Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory …See details»
Overview, News & Similar companies - ZoomInfo.com
Dec 27, 2021 View Sorriso Pharmaceuticals (www.sorrisopharma.com) location in Campania, Italy , revenue, industry and description. Find related and similar companies as well as …See details»
Sorriso Pharmaceuticals Presents Positive SOR102 Phase 1b …
Feb 27, 2025 For more information, please visit www.sorrisopharma.com. 1. Mayo Score clinical response: decrease from study baseline total Mayo score of ⩾3 points and ⩾30%, plus a …See details»
Sorriso Pharmaceuticals – Magnify Incubator at CNSI
Market: Sorriso’s products are designed to block multiple molecular targets that drive inflammation, as validated by rigorous research. The company’s biologic therapies are …See details»
Sorriso Pharmaceuticals Launches with $31 Million to Develop …
Dec 22, 2021 Series A Financing Funds Multiple Programs to Phase 1 and IND stage. SALT LAKE CITY, Dec. 22, 2021 /PRNewswire/ -- Sorriso Pharmaceuticals, a company focused on …See details»
Sorriso Pharmaceuticals - Work in biotech
Sorriso Pharmaceuticals is developing novel orally delivered cytokine antibodies for the treatment of inflammatory diseases. Their proprietary platform, Vorabodies, leverages single-domain …See details»
Pipeline - Sorriso Pharmaceuticals
Sorriso is building a pipeline of novel oral antibodies to address unmet need in various immune-mediated diseases.See details»
Sorriso Pharmaceuticals - CB Insights
CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve …See details»